Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With MET Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies

Autor: Lau, Sally C.M., Perdrizet, Kirstin, Fung, Andrea S., Mata, Danilo Giffoni M.M., Weiss, Jessica, Holzapfel, Nick, Liu, Geoffrey, Bradbury, Penelope A., Shepherd, Frances A., Sacher, Adrian G., Feilotter, Harriet, Sheffield, Brandon, Hwang, David, Tsao, Ming Sound, Cheng, Susanna, Cheema, Parneet, Leighl, Natasha B.
Zdroj: In JTO Clinical and Research Reports October 2023 4(10)
Databáze: ScienceDirect